rs963221673
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_033087.4(ALG2):c.1177A>G(p.Arg393Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033087.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 14Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ALG2-congenital disorder of glycosylationInheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- congenital myasthenic syndromes with glycosylation defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALG2 | NM_033087.4 | c.1177A>G | p.Arg393Gly | missense_variant | Exon 2 of 2 | ENST00000476832.2 | NP_149078.1 | |
| ALG2 | XM_047423996.1 | c.898A>G | p.Arg300Gly | missense_variant | Exon 2 of 2 | XP_047279952.1 | ||
| ALG2 | NR_024532.2 | n.1384A>G | non_coding_transcript_exon_variant | Exon 3 of 3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALG2 | ENST00000476832.2 | c.1177A>G | p.Arg393Gly | missense_variant | Exon 2 of 2 | 1 | NM_033087.4 | ENSP00000417764.1 | ||
| ALG2 | ENST00000319033.7 | c.898A>G | p.Arg300Gly | missense_variant | Exon 2 of 2 | 1 | ENSP00000326609.6 | |||
| ALG2 | ENST00000238477.5 | n.*919A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | ENSP00000432675.2 | ||||
| ALG2 | ENST00000238477.5 | n.*919A>G | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000432675.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74384 show subpopulations
ClinVar
Submissions by phenotype
ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). ClinVar contains an entry for this variant (Variation ID: 566269). This variant has not been reported in the literature in individuals affected with ALG2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 393 of the ALG2 protein (p.Arg393Gly). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at